BeyondSpring Inc. (BYSI) stock
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.60−0.04 (-6.65%)
Close on Nov 12, 2026Market cap $24.71MP/E –Yield –
BeyondSpring EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
BeyondSpring's EPS for the twelve months ending Dec 31, 2021 was -$1.64. For fiscal 2021 it was -$1.64. The highest annual figure on record is -$0.22 in fiscal 2014.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$1.64 | – |
| FY2020 | Dec 31, 2020 | -$2.03 | – |
| FY2019 | Dec 31, 2019 | -$1.55 | – |
| FY2018 | Dec 31, 2018 | -$2.42 | – |
| FY2017 | Dec 31, 2017 | -$4.40 | – |
| FY2016 | Dec 31, 2016 | -$0.75 | – |
| FY2015 | Dec 31, 2015 | -$0.53 | – |
| FY2014 | Dec 31, 2014 | -$0.22 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$0.02 | -118.2% |
| Q1 FY2026 | Mar 31, 2026 | -$0.05 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.04 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.10 | – |
| Q1 FY2025 | Mar 31, 2025 | $0.11 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.05 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.04 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.08 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.24 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.47 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.49 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.44 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.52 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.48 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.46 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.58 | – |
| Q4 FY2019 | Dec 31, 2019 | -$0.52 | – |
| Q3 FY2019 | Sep 30, 2019 | -$0.37 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.32 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.32 | – |
| Q4 FY2018 | Dec 31, 2018 | -$0.61 | – |
| Q3 FY2018 | Sep 30, 2018 | -$0.65 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.54 | – |
| Q1 FY2018 | Mar 31, 2018 | -$0.61 | – |
| Q4 FY2017 | Dec 31, 2017 | -$0.70 | – |
| Q3 FY2017 | Sep 30, 2017 | -$0.68 | – |
| Q2 FY2017 | Jun 30, 2017 | -$0.61 | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.66 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.21 | – |
| Q3 FY2016 | Sep 30, 2016 | -$0.19 | – |
| Q2 FY2016 | Jun 30, 2016 | -$0.23 | – |
| Q1 FY2016 | Mar 31, 2016 | -$0.12 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?